Advanced search
Publication Cover
Postgraduate Medicine Volume 118, 2005 - Issue 6
Submit an article Journal homepage
0
Views
1
CrossRef citations to date
0
Altmetric
Symposium on Epilepsy

Management of Epilepsy in Adults: Treatment Guidelines

Louis F. Trost IIIDr Wender is on the advisory board of Enterix, GlaxoSmithKline, and Gl View. Dr Rosenberg is on the speakers’ bureau for Teva, Cephalon, Serono, and Berlex. Dr Brixner has received research support from Novartis. Dr Trost, Dr Suter, Ms Von Worley, and Dr Gunter disclose no financial Interests in this article. Partial funding for guideline development was obtained from Novartis and the CDC National Center for Chronic Disease Prevention and Health Promotion.
, MD,
Richard C. WenderDr Wender is on the advisory board of Enterix, GlaxoSmithKline, and Gl View. Dr Rosenberg is on the speakers’ bureau for Teva, Cephalon, Serono, and Berlex. Dr Brixner has received research support from Novartis. Dr Trost, Dr Suter, Ms Von Worley, and Dr Gunter disclose no financial Interests in this article. Partial funding for guideline development was obtained from Novartis and the CDC National Center for Chronic Disease Prevention and Health Promotion.
, MD,
Cary C. SuterDr Wender is on the advisory board of Enterix, GlaxoSmithKline, and Gl View. Dr Rosenberg is on the speakers’ bureau for Teva, Cephalon, Serono, and Berlex. Dr Brixner has received research support from Novartis. Dr Trost, Dr Suter, Ms Von Worley, and Dr Gunter disclose no financial Interests in this article. Partial funding for guideline development was obtained from Novartis and the CDC National Center for Chronic Disease Prevention and Health Promotion.
, MD,
Jay H. RosenbergDr Wender is on the advisory board of Enterix, GlaxoSmithKline, and Gl View. Dr Rosenberg is on the speakers’ bureau for Teva, Cephalon, Serono, and Berlex. Dr Brixner has received research support from Novartis. Dr Trost, Dr Suter, Ms Von Worley, and Dr Gunter disclose no financial Interests in this article. Partial funding for guideline development was obtained from Novartis and the CDC National Center for Chronic Disease Prevention and Health Promotion.
, MD,
Diana I. BrixnerDr Wender is on the advisory board of Enterix, GlaxoSmithKline, and Gl View. Dr Rosenberg is on the speakers’ bureau for Teva, Cephalon, Serono, and Berlex. Dr Brixner has received research support from Novartis. Dr Trost, Dr Suter, Ms Von Worley, and Dr Gunter disclose no financial Interests in this article. Partial funding for guideline development was obtained from Novartis and the CDC National Center for Chronic Disease Prevention and Health Promotion.
, PhD, RPh,
Ann Marie Von WorleyDr Wender is on the advisory board of Enterix, GlaxoSmithKline, and Gl View. Dr Rosenberg is on the speakers’ bureau for Teva, Cephalon, Serono, and Berlex. Dr Brixner has received research support from Novartis. Dr Trost, Dr Suter, Ms Von Worley, and Dr Gunter disclose no financial Interests in this article. Partial funding for guideline development was obtained from Novartis and the CDC National Center for Chronic Disease Prevention and Health Promotion.
, RN,
Margaret J. GunterDr Wender is on the advisory board of Enterix, GlaxoSmithKline, and Gl View. Dr Rosenberg is on the speakers’ bureau for Teva, Cephalon, Serono, and Berlex. Dr Brixner has received research support from Novartis. Dr Trost, Dr Suter, Ms Von Worley, and Dr Gunter disclose no financial Interests in this article. Partial funding for guideline development was obtained from Novartis and the CDC National Center for Chronic Disease Prevention and Health Promotion.
, PhD & National Epilepsy Management Panel show all
Pages 29-33 | Published online: 21 Feb 2023

References

  • McAuley JW, Biederman TS, Smith JC, et al. Newer therapies in the drug treatment of epilepsy. Ann Pharmacother 2002; 36(1): 119-29
  • Perucca E. Clinical pharmacology and therapeutic use of the new antiepileptic drugs. Fundam Clin Pharmacol 2001; 15(6): 405-17 [Erratum, Fundam Clin Pharmacol 2002; 16(3): 249]
  • Bezchlibnyk-Butler KZ, Jeffries JJ, eds. Clinical handbook of psychotropic drugs. 13th ed. Cambridge, Mass: Hogrefe and Huber, 2003
  • Gidal BE, Garnett WR, Graves N. Epilepsy. In: DiPiro JT, Talbert RL, Yee GR, eds. Pharmacotherapy: a pathophysiologic approach. 5th ed. New York: McGraw-Hill, 2002: 1031-59
  • French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs. I: treatment of new-onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004; 62(8): 1252-60
  • Karceski S, Morrell MJ, Carpenter D. Treatment of epilepsy in adults: expert opinion, 2005. Epilepsy Behav 2005; 7(Suppl 1): S1-64
  • Beydoun A, Passaro EA. Appropriate use of medications for seizures. Guiding principles on the path of efficacy. Postgrad Med 2002; 111(1): 69-82
  • Sirven JI. Antiepileptic drug therapy for adults: when to initiate and how to choose. Mayo Clin Proc 2002; 77(12): 1367-75
  • Patsalos PN, Froscher W, Pisani F, et al. The importance of drug interactions in epilepsy therapy. Epilepsia 2002; 43(4): 365-85
  • Wiebe S, Blume WT, Girvin JP, et al; Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001; 345(5): 311-8
  • Eadie MJ. Therapeutic drug monitoring: antiepileptic drugs. Br J Clin Pharmacol 2001; 52(Suppl 1): 11-20S
  • Browne TR, Holmes GL. Epilepsy. N Engl J Med 2001; 344(15): 1145-51 [Erratum, N Engl J Med 2001; 344(25): 1956]
  • Practice parameter: a guideline for discontinuing antiepileptic drugs in seizure-free patients—summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996; 47(2): 600-2
  • Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1998; 51(4): 944-8
  • ACOG educational bulletin. Seizure disorders in pregnancy. Number 231, December 1996. Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1997; 56(3): 279-86
  • Morrell MJ. Epilepsy in women. Am Fam Physician 2002; 66(8): 1489-94
  • Leppik IE. Treatment of epilepsy in 3 specialized populations. Am J Manag Care 2001; 7(7 Suppl): S221-6
  • Krauss GL, Ampaw L, Krumholz A. Individual state driving restrictions for people with epilepsy in the US. Neurology 2001; 57(10): 1780-5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.